UK Avoids 'Cliff Edge' By Extending EU Drug Approval Reliance Procedure

 
• By Ian Schofield

The UK drugs regulator says it needs to make sure that companies do not “deprioritize” GB approval applications while a new “international reliance framework” is being developed.

Plenty of capsules and pills laying on a flag of Great Britain
The UK MHRA will continue to allow reliance on EU drug approvals for another year • Source: Shutterstock

More from Archive

More from Pink Sheet